# Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity

> **NCT04769037** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Helmholtz Zentrum München** · enrollment: 1149 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DIETARY_SUPPLEMENT:** B. infantis
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04769037
- **Lead sponsor:** Helmholtz Zentrum München
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-22
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 1149 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04769037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04769037, "Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04769037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*